- Baxter World Trade Corp has formed a joint venture with Indonesia's leading drugmaker P T Kalbe Farma to manufacture and market health care products. Under the terms of the deal, Baxter has acquired 51% of Kalbe's subsidiary Pfrimmer Infusol, and it will call for the expansion of existing Pfrimmer facilities to produce IV solutions in Baxter's Viaflex containers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze